Tumor SHB gene expression affects disease characteristics in human acute myeloid leukemia

The mouse Shb gene coding for the Src Homology 2-domain containing adapter protein B has recently been placed in context of BCRABL1-induced myeloid leukemia in mice and the current study was performed in order to relate SHB to human acute myeloid leukemia (AML). Publicly available AML databases were mined for SHB gene expression and patient survival. SHB gene expression was determined in the Uppsala cohort of AML patients by qPCR. Cell proliferation was determined after SHB gene knockdown in leukemic cell lines. Despite a low frequency of SHB gene mutations, many tumors overexpressed SHB mRNA compared with normal myeloid blood cells. AML patients with tumors expressing low SHB mRNA displayed longer survival times. A subgroup of AML exhibiting a favorable prognosis, acute promyelocytic leukemia (APL) with a PMLRARA translocation, expressed less SHB mRNA than AML tumors in general. When examining genes co-expressed with SHB in AML tumors, four other genes (PAX5, HDAC7, BCORL1, TET1) related to leukemia were identified. A network consisting of these genes plus SHB was identified that relates to certain phenotypic characteristics, such as immune cell, vascular and apoptotic features. SHB knockdown in the APL PMLRARA cell line NB4 and the monocyte/macrophage cell line MM6 adversely affected proliferation, linking SHB gene expression to tumor cell expansion and consequently to patient survival. It is concluded that tumor SHB gene expression relates to AML survival and its subgroup APL. Moreover, this gene is included in a network of genes that plays a role for an AML phenotype exhibiting certain immune cell, vascular and apoptotic characteristics.

[1]  S. Swerdlow.  WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues , 2017 .

[2]  Claude Preudhomme,et al.  A 17-gene stemness score for rapid determination of risk in acute leukaemia , 2016, Nature.

[3]  M. Riese,et al.  The adhesion molecule PECAM-1 enhances the TGF-β–mediated inhibition of T cell function , 2016, Science Signaling.

[4]  Ole Winther,et al.  BloodSpot: a database of gene expression profiles and transcriptional programs for healthy and malignant haematopoiesis , 2015, Nucleic Acids Res..

[5]  M. Welsh,et al.  The role of the Src Homology-2 domain containing protein B (SHB) in β cells. , 2016, Journal of molecular endocrinology.

[6]  M. Welsh,et al.  Vascular dysfunction and increased metastasis of B16F10 melanomas in Shb deficient mice as compared with their wild type counterparts , 2015, BMC Cancer.

[7]  Cheng Cheng,et al.  The landscape of somatic mutations in Infant MLL rearranged acute lymphoblastic leukemias , 2015, Nature Genetics.

[8]  S. Yohe.  Molecular Genetic Markers in Acute Myeloid Leukemia , 2015, Journal of clinical medicine.

[9]  Christopher C. Porter,et al.  Germline mutations in ETV6 are associated with thrombocytopenia, red cell macrocytosis and predisposition to lymphoblastic leukemia , 2015, Nature Genetics.

[10]  M. Esteller,et al.  The transcriptional repressor HDAC7 promotes apoptosis and c-Myc downregulation in particular types of leukemia and lymphoma , 2015, Cell Death and Disease.

[11]  M. Welsh,et al.  Absence of the adaptor protein Shb potentiates the T helper type 2 response in a mouse model of atopic dermatitis , 2014, Immunology.

[12]  Michael G. Kharas,et al.  The Src homology-2 protein Shb modulates focal adhesion kinase signaling in a BCR-ABL myeloproliferative disorder causing accelerated progression of disease , 2014, Journal of Hematology & Oncology.

[13]  Gang Wu,et al.  VEGF-PKD1-HDAC7 signaling promotes endothelial progenitor cell migration and tube formation. , 2014, Microvascular research.

[14]  C. Humbrecht,et al.  First description of the t(10;11)(q22;q23)/MLL-TET1 translocation in a T-cell lymphoblastic lymphoma, with subsequent lineage switch to acute myelomonocytic myeloid leukemia , 2013, Haematologica.

[15]  A. Cherry,et al.  B-cell transcription factor expression and immunoglobulin gene rearrangement frequency in acute myeloid leukemia with t(8;21)(q22;q22). , 2013, American journal of clinical pathology.

[16]  G. Daley,et al.  The Src homology 2 protein Shb promotes cell cycle progression in murine hematopoietic stem cells by regulation of focal adhesion kinase activity. , 2013, Experimental cell research.

[17]  R. Jaenisch,et al.  TET1 plays an essential oncogenic role in MLL-rearranged leukemia , 2013, Proceedings of the National Academy of Sciences.

[18]  Benjamin J. Raphael,et al.  Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. , 2013, The New England journal of medicine.

[19]  Benjamin E. Gross,et al.  Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal , 2013, Science Signaling.

[20]  Ulrich Mansmann,et al.  Identification of a 24-gene prognostic signature that improves the European LeukemiaNet risk classification of acute myeloid leukemia: an international collaborative study. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  Ole Winther,et al.  HemaExplorer: a database of mRNA expression profiles in normal and malignant haematopoiesis , 2012, Nucleic Acids Res..

[22]  M. Welsh,et al.  Aberrant association between vascular endothelial growth factor receptor-2 and VE-cadherin in response to vascular endothelial growth factor-a in Shb-deficient lung endothelial cells. , 2013, Cellular signalling.

[23]  K. Döhner,et al.  Mutated regions of nucleophosmin 1 elicit both CD4(+) and CD8(+) T-cell responses in patients with acute myeloid leukemia. , 2012, Blood.

[24]  Stein Aerts,et al.  High Accuracy Mutation Detection in Leukemia on a Selected Panel of Cancer Genes , 2012, PloS one.

[25]  M. Welsh,et al.  Heterogeneity among RIP‐Tag2 insulinomas allows vascular endothelial growth factor‐A independent tumor expansion as revealed by studies in Shb mutant mice: Implications for tumor angiogenesis , 2012, Molecular oncology.

[26]  M. Welsh,et al.  Vascular adaptation to a dysfunctional endothelium as a consequence of Shb deficiency , 2012, Angiogenesis.

[27]  Benjamin E. Gross,et al.  The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. , 2012, Cancer discovery.

[28]  A. Kohlmann,et al.  The corepressors BCOR and BCORL1: two novel players in acute myeloid leukemia , 2012, Haematologica.

[29]  R. Arceci.  Chronic Immune Stimulation Might Act As a Trigger for the Development of Acute Myeloid Leukemia or Myelodysplastic Syndromes , 2011 .

[30]  W. Gorczyca,et al.  Immunophenotypic pattern of myeloid populations by flow cytometry analysis. , 2011, Methods in cell biology.

[31]  V. Kríz,et al.  Shb deficient mice display an augmented TH2 response in peripheral CD4+ T cells , 2011, BMC Immunology.

[32]  C. Scrideli,et al.  research paper: Differential expression of HDAC3, HDAC7 and HDAC9 is associated with prognosis and survival in childhood acute lymphoblastic leukaemia , 2010, British journal of haematology.

[33]  R. Hills,et al.  Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials. , 2010, Blood.

[34]  Ying Sun,et al.  Dysfunctional microvasculature as a consequence of shb gene inactivation causes impaired tumor growth. , 2009, Cancer Research.

[35]  Bas J. Wouters,et al.  Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profiling , 2009, Haematologica.

[36]  A. Advani,et al.  Expression of the B cell-associated transcription factors PAX5, OCT-2, and BOB.1 in acute myeloid leukemia: associations with B-cell antigen expression and myelomonocytic maturation. , 2006, American journal of clinical pathology.

[37]  V. Kríz,et al.  The FRK/RAK-SHB signaling cascade: a versatile signal-transduction pathway that regulates cell survival, differentiation and proliferation. , 2003, Current molecular medicine.

[38]  W. Miller,et al.  Molecular cytogenetics of the acute promyelocytic leukemia‐derived cell line NB4 and of four all‐trans retinoic acid–resistant subclones , 2002, Genes, chromosomes & cancer.

[39]  W. Zhang,et al.  Requirement of the Src Homology 2 Domain Protein Shb for T Cell Receptor-dependent Activation of the Interleukin-2 Gene Nuclear Factor for Activation of T Cells Element in Jurkat T Cells* , 1999, The Journal of Biological Chemistry.

[40]  L. Cantley,et al.  Stimulation through the T cell receptor leads to interactions between SHB and several signaling proteins , 1998, Oncogene.

[41]  T. Pawson,et al.  Molecular interactions of the Src homology 2 domain protein Shb with phosphotyrosine residues, tyrosine kinase receptors and Src homology 3 domain proteins. , 1995, Oncogene.